Fragment-based approach to identify IDO1 inhibitor building blocks
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 141, 169-177
Abstract
No abstract availableKeywords
Funding Information
- Italian Ministry of University and Research (PRIN 2012S47X27)
- European Research Council (ERC-2013-AdG 338954-DIDO)
This publication has 33 references indexed in Scilit:
- Virtual Fragment Docking by Glide: a Validation Study on 190 Protein−Fragment ComplexesJournal of Chemical Information and Modeling, 2010
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in BioassaysJournal of Medicinal Chemistry, 2010
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathwayThe International Journal of Biochemistry & Cell Biology, 2009
- Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer diseaseAmino Acids, 2008
- Ligand efficiency indices for effective drug discoveryExpert Opinion on Drug Discovery, 2007
- Why molecules move along a temperature gradientProceedings of the National Academy of Sciences, 2006
- A ‘Rule of Three’ for fragment-based lead discovery?Drug Discovery Today, 2003
- Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseNature Medicine, 2003
- Tryptophan and the immune responseImmunology & Cell Biology, 2003
- The Protein Data BankNucleic Acids Research, 2000